About Alphatec Holdings, Inc. - Common Stock (ATEC)
Alphatec Holdings is a medical technology company focused on developing innovative surgical solutions for the spine. The company's offerings include advanced technology and instrumentation designed to assist healthcare professionals in performing spinal surgeries more effectively and safely. By leveraging a combination of research, engineering, and clinical expertise, Alphatec aims to enhance patient outcomes through its range of products that address various spinal conditions and improve the surgical experience. With a commitment to advancing spine surgery, the company prioritizes innovation and quality in its product development and service offerings. Read More
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Alphatec Holdings (ATEC) smashed Q3 2025 earnings estimates, beating on revenue and swinging to a profit. The stock surged over 21% as the company also raised its full-year 2025 guidance.
Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended September 30, 2025, and recent corporate highlights.
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report third quarter 2025 financial results on October 30, 2025, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET.
The pharmaceutical landscape is currently a tale of two giants employing vastly different, yet highly successful, growth strategies. Eli Lilly and Company (NYSE: LLY) has placed an extraordinary bet on the burgeoning market for weight-loss and diabetes drugs, driven by its groundbreaking GLP-1 agonists. In stark contrast, Johnson & Johnson (NYSE:
ATEC stock excels in both technical momentum and fundamental growth, meeting Mark Minervini's strict Trend Template criteria for high-growth investors.
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences:
Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended June 30, 2025, and recent corporate highlights.
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2025 financial results on July 31, 2025, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET.
